Acquired hypocalciuric hypercalcemia (Q65581): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/1325071304
@@ Property / Canonical URI: https://id.who.int/icd/entity/1325071304 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_1325071304
@@ Property / CURIE: CID11:ID_1325071304 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_1325071304
@@ Property / Canary Token: dki-india-ID_1325071304 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank

Latest revision as of 13:18, 14 August 2026

Patients with acquired hypocalciuric hypercalcaemia present the same clinical features to those with familial hypocalciuric hypercalcemia. While familial hypocalciuric hypercalcemia is caused by mutations in several genes including CASR which encodes calcium-sensin receptor, acquired hypocalciuric hypercalcaemia is caused by the production of inhibitory autoantibodies to calcium-sensing receptor.

Language	Label	Description	Also known as
default for all languages	ID_1325071304
English	Acquired hypocalciuric hypercalcemia	Patients with acquired hypocalciuric hypercalcaemia present the same clinical features to those with familial hypocalciuric hypercalcemia. While familial hypocalciuric hypercalcemia is caused by mutations in several genes including CASR which encodes calcium-sensin receptor, acquired hypocalciuric hypercalcaemia is caused by the production of inhibitory autoantibodies to calcium-sensing receptor.